Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-017180
Filing Date
2025-05-15
Accepted
2025-05-15 16:07:15
Documents
53
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi20250331_10q.htm   iXBRL 10-Q 805237
2 EXHIBIT 31.1 ex_756158.htm EX-31.1 12830
3 EXHIBIT 31.2 ex_756159.htm EX-31.2 12807
4 EXHIBIT 32.1 ex_756160.htm EX-32.1 4899
5 EXHIBIT 32.2 ex_756161.htm EX-32.2 4867
  Complete submission text file 0001437749-25-017180.txt   4565537

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20250331.xsd EX-101.SCH 47398
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20250331_cal.xml EX-101.CAL 20288
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20250331_def.xml EX-101.DEF 313894
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20250331_lab.xml EX-101.LAB 288229
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20250331_pre.xml EX-101.PRE 336466
56 EXTRACTED XBRL INSTANCE DOCUMENT atxi20250331_10q_htm.xml XML 591149
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 25952861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)